RADHA SAMTANI: Open Payments
NPI 1144882044 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,240 in 50 payments from 25 companies in 2025. Trend: 2023 $599 · 2024 $648 · 2025 $2,240
Food & beverage: $1,558Consulting: $683
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $810 |
| Eisai Inc. | 8 | $402 |
| AstraZeneca Pharmaceuticals LP | 6 | $264 |
| Janssen Biotech, Inc. | 3 | $185 |
| Exelixis Inc. | 3 | $84 |
| Genentech USA, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $42 |
| Incyte Corporation | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $29 |
Products named: Lenvima, RYBREVANT, KEYTRUDA, CABOMETYX, MONJUVI, CALQUENCE, JEMPERLI, TAGRISSO.
Industry payments across GA — which companies pay providers there.
